Secretion of plasminogen activator inhibitor 2 by human peripheral blood monocytes occurs via an Endoplasmic Reticulum-Golgi-independent pathway

Experimental Cell Research

Volumn 242, Issue 2, 1998, Pages 439-450

  Ritchie, Helen ^a   Booth, Nuala A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

ER Golgi independent; Monocytes; PAI 2; Secretion

Indexed keywords

LACTATE DEHYDROGENASE; PLASMINOGEN ACTIVATOR INHIBITOR 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEIN TRANSPORT;

EID: 0032145308     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4118     Document Type: Article

References (51)

1. Remold O'Donnell E. The ovalbumin family of serpin proteins. FEBS. Lett. 315:1993;105-108.
2. Zou Z., Anisowicz A., Hendrix M. J. C., Thor A., Neveu M., Sheng S., Rafidi K., Seftor E., Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 263:1994;526-529.
3. Coughlin P., Sun J., Cerruti L., Salem H. H., Bird P. Cloning and molecular characterization of a human intracellular serine proteinase inhibitor. Proc. Natl. Acad. Sci. USA. 90:1993;9417-9421.
4. Morgenstern K. A., Sprecher C. A., Holth L., Foster D., Grant F. J., Ching A., Kisiel W. Isolation and characterization of an intracellular serine proteinase inhibitor from a monkey kidney epithelial cell line. Biochemistry. 33:1994;3432-3441.
5. Sprecher C. A., Morgenstern K. A., Mathewes S., Dahlen J. R., Schrader S. K., Foster D. C., Kisiel W. Molecular cloning, expression and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors. J. Biol. Chem. 270:1995;29854-29861.
6. Riewald M., Schleef R. R. Molecular cloning of bomapin (protease inhibitor 10), a novel human serpin that is expressed specifically in the bone marrow. J. Biol. Chem. 270:1995;26754-26757.
7. Scott F. L., Coughlin P. B., Bird C., Cerruti L., Hayman J. A., Bird P. Proteinase inhibitor 6 cannot be secreted, which suggests a new type of cellular serpin. J. Biol. Chem. 271:1996;1605-1612.
8. Ritchie H., Jamieson A., Booth N. A. Thrombin modulates synthesis of plasminogen activator inhibitor 2 (PAI-2) by human peripheral blood monocytes. Blood. 86:1995;3428-3435.
9. Pytel B. A., Peppel K., Baglioni C. Plasminogen activator inhibitor type-2 is a major protein induced in human fibroblasts and SK-MEL-109 melanoma cells by tumor necrosis factor. J. Cell Physiol. 144:1990;416-422.
10. Jensen P. J., Wu Q., Janowitz P., Ando Y., Schechter N. M. Plasminogen activator inhibitor type 2: an intracellular keratinocyte differentiation product that is incorporated into the cornified envelope. Exp. cell res. 217:1995;65-72.
11. Gan H., Newman G. W., Remold H. G. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected withMycobacterium avium. J. Immunol. 155:1995;1304-1315.
12. Kumar S., Baglioni C. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem. 266:1991;20960-20964.
13. Dickinson J. L., Bates E. J., Ferrante A., Antalis T. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor α-induced apoptosis. J. Biol. Chem. 270:1995;27894-27904.
14. Martin S. J., Green D. R. Protease activation during apoptosis: Death by a thousand cuts. Cell. 82:1995;349-352.
15. Ray C. A., Black R. A., Kronheim S. R., Greenstreet T. A., Sleath P. R., Salvasen G. S., Pickup D. J. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell. 69:1992;597-604.
16. Booth N. A. Inhibitors of fibrinolysis. Haemostasis and Thrombosis. 1994;. p. 699-717.
17. Kruithof E. K. O., Baker M. S., Bunn C. L. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood. 86:1995;4007-4024.
18. Schwartz B. S., Monroe M. C., Levin E. G. Increased release of plasminogen activator inhibitor type 2 accompanies the human mononuclear tissue factor response to lipopolysaccharide. Blood. 71:1988;734-741.
19. Ritchie H., Jamieson A., Booth N. A. Peripheral blood monocyte synthesis of plasminogen activator inhibitor 2 (PAI-2) in response to native and modified LDL. Thromb. Haemost. 74:1995;1521-1527.
20. Booth N. A., Reith A., Bennett B. A plasminogen activator inhibitor (PAI-2) circulates in two forms during pregnancy. Thromb. Haemost. 59:1988;77-79.
21. Whawell S. A., Vipond M. N., Scott-Coombes D. M., Thompson J. N. PAI-2 reduces peritoneal fibrinolytic activity. Br. J. Surg. 80:1993;107-109.
22. Lyons-Giordano B., Loskutoff D., Chen C. S., Lazarus G., Keeton M., Jensen P. J. Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis. Histochemistry. 101:1994;105-112.
23. Kirchheimer J. C., Remold H. G. Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors. Blood. 74:1989;1396-1402.
24. Genton C., Kruithof E. K. O., Schleuning W.-D. Phorbol ester induced biosynthesis of glycosylated and non-glycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U937 lymphoma cells. J. Cell Biol. 104:1987;705-712.
25. Wohlwend A., Belin D., Vassalli J.-D. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages. J. Exp. Med. 165:1987;320-329.
26. Ye R. D., Wun T.-C., Sadler J. E. Mammalian protein secretion without signal peptide removal: Biosynthesis of PAI-2 in U937 cells. J. Biol. Chem. 263:1988;4869-4875.
27. Belin D., Wohlwend A., Schleuning W.-D., Kruithof E. K. O., Vassalli J.-D. Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of PAI-2. EMBO J. 8:1989;3287-3294.
28. von Heijne G., Liljestrom P., Mikus P., Andersson H., Ny T. The efficiency of the uncleaved secretion signal in the PAI-2 protein can be enhanced by point mutations that increase its hydrophobicity. J. Biol. Chem. 266:1991;15240-15243.
29. Belin D., Bost S., Vassalli J.-D., Strub K. A two-step recognition of signal sequences determines the translocation efficiency of proteins. EMBO J. 15:1996;468-478.
30. Mikus P., Urano T., Liljestrom P., Ny T. Plasminogen activator inhibitor type 2 (PAI-2) is a spontaneously polymerizing SERPIN. Eur. J. Biochem. 218:1993;1071-1082.
31. Mikus P., Ny T. Intracellular polymerization of the serpin plasminogen activator inhibitor type 2. J. Biol. Chem. 271:1996;10048-10053.
32. Nachlas M. M., Marguiles S. I., Goldberg J. D., Seligman A. M. The determination of lactic dehydrogenase with a tetrazolium salt. Anal. Biochem. 1:1960;317-326.
33. Buttke T. M., McCubrey J. A., Owen T. C. Use of an aqueous soluble tetrazolium formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J. Immunol. Methods. 157:1993;233-238.
34. Stevens J., Cottingham I. R., Chinery S. A., Goodey A. R., Courtney M., Ballance D. J. Purification and characterisation of plasminogen activator inhibitor 2 produced inSacc. cerevisiae. Eur. J. Biochem. 196:1991;431-438.
35. 2. Br. J. Pharmacol. 117:1996;1449-1456.
36. Rios R. M., Celati C., Lohmann S. M., Bornens M., Keryer G. Identification of a high affinity binding protein for the regulatory subunit RIIβ of cAMP-dependent protein kinase in Golgi enriched membranes of human lymphoblasts. EMBO J. 11:1992;1723-1731.
37. Berger E. G., Mandel T., Schlit U. Immunohistochemical localization of galactosyltransferase in human fibroblasts and HeLa cells. J. Histochem. Cytochem. 29:1981;364-370.
38. Rubartelli A., Cozzolino F., Talio M., Sitia R. A novel secretory pathway for interleukin-1β, a protein lacking a signal sequence. EMBO J. 9:1990;1503-1510.
39. Christmas P., Callaway J., Fallon J., Jones J., Haigler H. T. Selective secretion of annexin 1, a protein without a signal sequence, by the human prostate gland. J. Biol. Chem. 266:1991;2499-2507.
40. Comera C., Russo-Marie F. Glucocorticoid-induced annexin 1 secretion by monocytes and peritoneal leukocytes. Br. J. Pharmacol. 115:1995;1043-1047.
41. Rubartelli A., Bajetto A., Allavena G., Wollman E., Sitia R. Interleukin 1 β and thioredoxin are secreted through a novel pathway of secretion. Biochem. Soc. Tran. 19:1991;255-259.
42. Mignatti P., Morimoto S., Rifkin D. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the ER-Golgi complex. J. Cell Physiol. 151:1992;81-93.
43. Barondes S., Cooper D. W., Gitt M. A., Leffler H. Galectins. J. Biol. Chem. 269:1994;20807-20810.
44. Cooper D. N. W., Barondes S. H. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory pathway. J. Cell Biol. 110:1990;1681-1691.
45. Mehul B., Hughes R. C. Plasma membrane targetting, vesicular budding and release of galactin 3 from the cytoplasm of mammalian cells during secretion. J. Cell Sci. 110:1997;1169-1178.
46. Singer I. I., Scott S., Hall G. L., Limjuco G., Chin J., Schmidt J. A. Interleukin 1β is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes. J. Exp. Med. 167:1990;389-409.
47. Ritchie H., Jamieson A., Booth N. A. Regulation, location and activity of plasminogen activator inhibitor 2 (PAI-2) in peripheral blood monocytes, macrophages and foam cells. Thromb. Haemost. 77:1997;1168-1173.
48. Jensen P. H., Jensen T. G., Laug W. E., Hager H., Gliemann J., Pepinsky B. The exon 3 encoded sequence of the intracellular serine proteinase inhibitor plasminogen activator inhibitor 2 is a protein binding domain. J. Biol. Chem. 271:1996;26892-26899.
49. Jensen P. H., Lorand L., Ebbesen P., Gliemann J. Type-2 plasminogen activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa-transglutaminase-catalyzed cross-linking to cellular and extracellular structures. Eur. J. Biochem. 214:1993;141-146.
50. Aeschlimann D., Paulsson M. Transglutaminases: Protein cross-linking enzymes in tissues and body fluids. Thromb. Haemost. 71:1994;402-415.
51. Muesch A., Hartmann E., Rohde K., Rubartelli A., Sitia R., Rapoport T. A. A novel pathway for secretory proteins. Trends Biochem. Sci. 15:1990;88-86.